REQUEST A DEMO
Total
USD $0.00
Search more companies

Cbio Project Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Cbio Project Sp. z o.o. Profile Updated: June 30, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Cbio Project Sp. z o.o. is based in Poland, with the head office in Lublin. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was established on April 24, 2019. From the latest financial highlights, Cbio Project Sp. z o.o. reported a net sales revenue drop of 17.97% in 2022. Its’ total assets recorded a growth of 17.33%. Cbio Project Sp. z o.o.’s net profit margin decreased by 30.28% in 2022.

Headquarters
Ul. Bohdana Dobrzanskiego 3
Lublin; Lubelskie; Postal Code: 20-262

Contact Details: Purchase the Cbio Project Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Cbio Project Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Cbio Project Sp. z o.o. report to view the information.
Incorporation Date:
April 24, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Cbio Project Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-17.97%
Total operating revenue
-17.98%
Operating profit (EBIT)
-387.95%
Net Profit (Loss) for the Period
-387.95%
Total assets
17.33%
Total equity
-36.08%
Operating Profit Margin (ROS)
-30.28%
Net Profit Margin
-30.28%
Return on Equity (ROE)
-49.05%
Quick Ratio
-1.15%
Cash Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?